Clinical trial

A Randomised Controlled Clinical Trial in Type 2 Diabetes Comparing Semaglutide to Placebo and Liraglutide

NCT00696657

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-06-03

PhasePHASE2

Study timeline

Study start (actual)2008-06-03Date precision: day

Registry last updated2019-08-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 2unresolved

Interventions

semaglutideDRUG · verified · RxNorm: semaglutide

placeboDRUG

liraglutideDRUG · verified · RxNorm: liraglutide

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

IstanbulTurkey (Türkiye)4 ViennaAustria4 SofiaBulgaria3 MadridSpain2 BudapestHungary1 HamburgGermany1 ValenciaSpain1 SevilleSpain1 MontpellierFrance1 NaplesItaly1 DebrecenHungary1 PlovdivBulgaria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00696657 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.